Summary
This article presents results from a randomized trial demonstrating a reduction in subsequent fractures in patients with intertrochanteric fractures who were treated with risedronate and received follow-up care with quantitative ultrasound to monitor the existing fracture and bone status.
- Bone Density & Structure Disorders
- Metabolic Bone Disease
- Orthopaedics Clinical Trials
- Metabolic Bone Disease
- Orthopaedics
- Bone Density & Structure Disorders
- Metabolic Bone Disease
- Orthopaedics Clinical Trials
- Metabolic Bone Disease
- © 2014 MD Conference Express®
Tools
Risedronate and Follow-up Quantitative Ultrasound Reduces Refracture in Osteoporosis
Permalink:
Table of contents
Cited By...
- No citing articles found.